COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Srdan Verstovsek, MD, PhD
M.D. Anderson Cancer Center
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
112 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Darlinghurst, New South Wales, Australia
- Facility name not stated
Kogarah, New South Wales, Australia
- Facility name not stated
Randwick, New South Wales, Australia
- Facility name not stated
St Leonards, New South Wales, Australia
- Facility name not stated
Brisbane, Queensland, Australia
- Facility name not stated
Douglas, Queensland, Australia
- Facility name not stated
Herston, Queensland, Australia
- Facility name not stated
Milton, Queensland, Australia
- Facility name not stated
Woolloongabba, Queensland, Australia
- Facility name not stated
Bedford Park, South Australia, Australia
- Facility name not stated
Box Hill, Victoria, Australia
- Facility name not stated
Clayton, Victoria, Australia
- Facility name not stated
Frankston, Victoria, Australia
- Facility name not stated
Ringwood East, Victoria, Australia
- Facility name not stated
Fremantle, Western Australia, Australia
- Facility name not stated
Perth, Western Australia, Australia
- Facility name not stated
Vancouver, British Columbia, Canada
- Facility name not stated
St. John's, Newfoundland and Labrador, Canada
- Facility name not stated
Halifax, Nova Scotia, Canada
- Facility name not stated
London, Ontario, Canada
- Facility name not stated
Ottawa, Ontario, Canada
- Facility name not stated
Toronto, Ontario, Canada
- Facility name not stated
Lévis, Quebec, Canada
- Facility name not stated
Montreal, Quebec, Canada
- Facility name not stated
Birmingham, Alabama, United States
- Facility name not stated
Scottsdale, Arizona, United States
- Facility name not stated
Baldwin Park, California, United States
- Facility name not stated
Bellflower, California, United States
- Facility name not stated
Beverly Hills, California, United States
- Facility name not stated
Corona, California, United States
- Facility name not stated
Fullerton, California, United States
- Facility name not stated
Highland, California, United States
- Facility name not stated
La Jolla, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Orange, California, United States
- Facility name not stated
Palo Alto, California, United States
- Facility name not stated
Panorama City, California, United States
- Facility name not stated
Rancho Cucamonga, California, United States
- Facility name not stated
Riverside, California, United States
- Facility name not stated
Sacramento, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2009
- Primary completion
- 30 Nov 2010
- Completion
- 31 Oct 2015
- Last update posted
- 12 Mar 2018
- Registered enrollment
- 309
- Registry id
- NCT00952289
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.